Questions and answers for international patients

Send your reports on WhatsApp or to info@birunibridge.com, or leave your details in the form and a coordinator who speaks your language will contact you and ask for anything missing.

Your latest medical report, imaging reports (DICOM images preferred), biopsy report if any, recent blood tests and a dated list of previous treatments.

Yes. The remote review of your medical file is free and does not commit you to anything.

Usually within 24–48 hours of a complete file. Complex cases may take longer.

Physicians in the relevant specialty, and several specialties for complex cases.

It is a proposed plan. It may change after assessment on arrival; any change is explained before starting.

Pricing is case by case after reviewing your medical report.

In many cases, through pre-authorization or direct billing.

Yes. A medical invitation letter, airport pick-up, transfer and accommodation for you and your companion.

Yes. 24/7.

Your coordinator and an interpreter when needed; your companion can stay under hospital policy.

We tell you straight away and help extend your stay and visa.

A detailed discharge summary, remote follow-up and contact with your local doctor.

Yes. CAR-T cell therapy is available at Biruni University Hospital for eligible patients. The hematology and transplant team decides eligibility after reviewing your file; not every patient is a candidate and no result can be guaranteed. Read: CAR-T cell therapy in Turkey, your questions answered

T cells from your blood are modified in a lab to recognize a target on cancer cells (such as CD19) and returned in one infusion. It may help in some advanced blood cancers but does not work for everyone. (Source: NCI)

A cure cannot be promised. Some patients achieve long remission; others do not respond or relapse.

Usually patients whose disease returned or did not respond to standard treatment. The team assesses disease type and target, general health, heart, kidney, liver and lung function; Biruni’s hematology and transplant team makes the final decision.

Biopsy report with immunostaining (e.g. CD19), PET-CT reports, previous treatments with dates, recent full blood tests and a recent medical report. Your coordinator tells you if the team needs anything else.

Assessment → cell collection → manufacturing → sometimes bridging therapy → conditioning chemotherapy → infusion (usually under 30 minutes) → close monitoring and long-term follow-up.

Typically about 3–5 weeks from collection to infusion (NCI). The team gives you the expected timeline for your case.

Cytokine release syndrome (fever, low blood pressure, breathing difficulty), neurological toxicity (confusion, speech difficulty), low blood counts and infection risk, sometimes serious.

Current standards in some countries require at least two weeks near a specialist center; many centers ask international patients to stay longer. At Biruni, the team sets the exact period for your case before you travel.

Usually yes: an adult available around the clock in the first weeks. Your coordinator explains the companion arrangements.

Pricing is case by case after reviewing your medical report. Always ask for a written estimate that states what is included, including complications and intensive care.

Regular blood tests, immunoglobulin levels, imaging and contact between the center and your local doctor; long-term follow-up is recommended. Biruni’s team agrees the follow-up plan with you and your doctor.

An approved product has been reviewed by a regulator for a specific use; a trial tests a new treatment or use, with less certain results and risks. Always ask for the trial registration number.

Reports you send by WhatsApp or email are handled by the international patient team and shared only with the medical team reviewing your case.

Yes, under your rights in the KVKK personal data law (Article 11).